AzTrials
AzTrials

Anterior Cruciate Ligament Reconstruction RehabilitationNCT07311031

Effect of Blood Flow Restriction Rraining on Rehabilitation After Anterior Cruciate Ligament Reconstruction

A study testing Blood flow restriction training and Standard ACL rehabilitation in people with Anterior Cruciate Ligament Reconstruction Rehabilitation and Blood Flow Restriction (BFR) Training Effects, run by Hospital MAZ at 1 site in Spain.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Importance: Following anterior cruciate ligament reconstruction (ACLR), patients often experience quadriceps muscle weakness and atrophy, frequently leading to long-term complications. Read more about this study

Who is it for?
Ages 18 to 65 years
What is being tested?
Blood flow restriction training and Standard ACL rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteSpain
Study dates
20 Dec 2025to 1 Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male or female (18-65 years of age); must be skeletally mature with closed physes
  • Worker active
  • Diagnosis of acute (<8 weeks), unilateral ACL tear with planned surgery confirmed via clinical examination and MRI
  • No previous ACL injury or reconstruction on the involved limb
  • Planned graft: autologous ipsilateral hamstring graft for ACL reconstruction
  • Planned fixation: suspensory cortical femoral device and tibial interference screw

Who cannot join

  • Completed knee dislocation or multiligament injury (PCL, MCL, LCL)
  • ACL Graft diameter < 8mm
  • Meniscal suture or meniscal root reattachment
  • Post-surgical immobilization
  • Any current or previous conditions or surgeries that might affect gait
  • Pregnant
Show all 15Show fewer
  • Spinal fusion
  • Any implanted medical device or other contraindications for MRI
  • History of deep vein thrombosis and/or varicose veins or familiy history of deep vein thrombosis
  • Taking anti-coagulant drugs for any blood, cardiac or congenital disease that may cause coagulation disorders
  • Taking bone and muscle metabolism-modulation drugs or muscle supplements (e.g., creatine, amino acids, whey protein,…)
  • Recent inflammation, bleeding disorders, active bleeding, or infection within the lower limbs
  • Diabetic or have uncontrolled hypertension
  • Diminished capacity to provide informed consent
  • Unfeasible to attend regular physical therapy and study visits

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Raul Zapata-Rodrigo, Orthopaedic Surgeon contact

+34620727950

raulzapatarodrigo@gmail.com

Spain1 site
  • MAZ Hospital

    Zaragoza, Zaragoza, 50009

    Raul Zapata-Rodrigo, Orthopaedic Surgeon, +34620727950, raulzapatarodrigo@gmail.com

Other trials in Spain

About this study

Official title: Effect of Blood Flow Restriction Training on Quadriceps Muscle Strength, Knee Biomechanics and Rehabilitation After Anterior Cruciate Ligament Reconstruction in Active Workers

Importance: Following anterior cruciate ligament reconstruction (ACLR), patients often experience quadriceps muscle weakness and atrophy, frequently leading to long-term complications. A promising rehabilitation program based on blood flow restriction training (BFRT) seems to be particularly valuable for patients who may be unable to train with heavy loads due recent surgery. Previous studies have demonstrated that BFRT promotes strength gains and muscle mass increases, with adaptations comparable to traditional high-intensity training, despite using low-load resistance exercises.

Objective: to evaluate the effect of blood flow restriction training on quadriceps strength and knee biomechanics in a 4-month rehabilitation program of patients who have had an ACL reconstruction.

Read more

Design: The study will be a two-arm superiority randomized controlled clinical trial.

Setting: The trial will be conducted at a work-related injuries specialised hospital, MAZ Hospital, Zaragoza, Spain.

Participants: Participants will be active workers who have suffered an acute ACL tear and they have undergone ACL reconstruction (n=60).

Intervention: Patients will recieve a 14-16-week supervised accelerated early rehabilitation protocol; one group will complete it applying blood flow restriction training and the other will not.

Main Outcome and Measure: The primary outcomes will be peak quadriceps strength and rate of torque development measured both isometrically and isokinetcally with a Isokinetic Dynamometer CON-TREX MG.

Limitations: Potential limitations include patients and physiotherapists are not blinded.

Conclusions: The focus of the research will examine the impact of blood flow restriction rehabilitation on patients who have undergone ACLR.

Relevance: The study has potential to restore quadriceps strength to a greater extent than standard rehabilitation protocol. Moreover, patients will spend less time in the rehabilitation process to return to work compared to standard care.

Being tested
Blood flow restriction training, Standard ACL rehabilitation
Keywords
KAATSU, Knee injury, ACL rehabilitation
Medical subject headings
Knee Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood flow restriction trainingOther

    BFRT consists of a pressurized cuff that is applied to the proximal thigh in order to partially occlude blood flow while the patient exercises. It is believed that the accumulated effects of fatigue, mechanical tension, metabolic stress and reactive hyperaemia contribute to promoting adaptation of the quadriceps with minimal strain. Therefore, patients can train at reduced loads and may receive the same training benefits as if they were training with high loads.

  • Standard ACL rehabilitationOther

    A 14-16-week supervised accelerated early rehabilitation protocol was selected based on previous evidence.8 It is characterised by early unrestricted motion and weight-bearing, without the use of an immobilising brace and commencing early strength training.

Study groups in NCT07311031
Study groupRoleWhat they receive
BFRT rehabilitation groupExperimentalReceive standard ACL physical therapy plus blood flow restriction training
Receives: Other: Blood flow restriction training; Other: Standard ACL rehabilitation
Standard rehabilitation groupActive comparatorReceive standard ACL physical therapy
Receives: Other: Standard ACL rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quadriceps strength

    Peak quadriceps strength

    Measured: From enrollment to the end of treatment at 14 weeks

  2. Quadriceps strength

    Rate of torque

    Measured: From enrollment to the end of treatment at 14 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Dec 2025
  2. Study start20 Dec 2025 (estimated)
  3. Primary completion1 Sep 2026 (estimated)
  4. Study completion1 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07311031
Sponsor's protocol ID
MAZ Hospital
Status last verified
Dec 2025
First submitted
16 Dec 2025
Last updated
5 Jan 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Trained researchers will collect data from MAZ Hospital. All information collected during this trial will always be protected and securely stored by the lead researcher. The lead researcher will assign a secure locker in his office to store all investigation documents. Additionally, all electronic material will be safely stored and backed up on the researcher's computer equipment with a secure password.

Publications

  • Erickson LN, Lucas KCH, Davis KA, Jacobs CA, Thompson KL, Hardy PA, Andersen AH, Fry CS, Noehren BW. Effect of Blood Flow Restriction Training on Quadriceps Muscle Strength, Morphology, Physiology, and Knee Biomechanics Before and After Anterior Cruciate Ligament Reconstruction: Protocol for a Randomized Clinical Trial. Phys Ther. 2019 Aug 1;99(8):1010-1019. doi: 10.1093/ptj/pzz062.

    PubMed 30951598
  • Gopinatth V, Garcia JR, Reid IK, Knapik DM, Verma NN, Chahla J. Blood Flow Restriction Enhances Recovery After Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Arthroscopy. 2025 Apr;41(4):1048-1060. doi: 10.1016/j.arthro.2024.05.032. Epub 2024 Jun 16.

    PubMed 38889851
  • Erickson LN, Owen MK, Casadonte KR, Janatova T, Lucas K, Spencer K, Brightwell BD, Graham MC, White MS, Thomas NT, Latham CM, Jacobs CA, Conley CE, Thompson KL, Johnson DL, Hardy PA, Fry CS, Noehren B. The Efficacy of Blood Flow Restriction Training to Improve Quadriceps Muscle Function after Anterior Cruciate Ligament Reconstruction. Med Sci Sports Exerc. 2025 Feb 1;57(2):227-237. doi: 10.1249/MSS.0000000000003573. Epub 2024 Oct 1.

    PubMed 39350350
  • Mather RC 3rd, Koenig L, Kocher MS, Dall TM, Gallo P, Scott DJ, Bach BR Jr, Spindler KP; MOON Knee Group. Societal and economic impact of anterior cruciate ligament tears. J Bone Joint Surg Am. 2013 Oct 2;95(19):1751-9. doi: 10.2106/JBJS.L.01705.

    PubMed 24088967
  • Matar HE, Platt SR, Bloch BV, James PJ, Cameron HU. A Systematic Review of Randomized Controlled Trials in Anterior Cruciate Ligament Reconstruction: Standard Techniques Are Comparable (299 Trials With 25,816 Patients). Arthrosc Sports Med Rehabil. 2021 May 14;3(4):e1211-e1226. doi: 10.1016/j.asmr.2021.03.017. eCollection 2021 Aug.

    PubMed 34430902

Questions about this trial

What is this clinical trial studying?

A study testing Blood flow restriction training and Standard ACL rehabilitation in people with Anterior Cruciate Ligament Reconstruction Rehabilitation and Blood Flow Restriction (BFR) Training Effects, run by Hospital MAZ at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 5 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Raul Zapata-Rodrigo, Orthopaedic Surgeon (+34620727950, raulzapatarodrigo@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quadriceps strength (time frame: From enrollment to the end of treatment at 14 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07311031, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in